Timothy B. Lowinger
2017
In 2017, Timothy B. Lowinger earned a total compensation of $518K as Senior Vice President and Chief Scientific Officer at Mersana Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $141,803 |
|---|---|
| Salary | $370,162 |
| Other | $6,000 |
| Total | $517,965 |
Lowinger received $370.2K in salary, accounting for 71% of the total pay in 2017.
Lowinger also received $141.8K in non-equity incentive plan and $6K in other compensation.
Rankings
In 2017, Timothy B. Lowinger's compensation ranked 11,717th out of 14,666 executives tracked by ExecPay. In other words, Lowinger earned more than 20.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,717 out of 14,666 | 20th |
Division Manufacturing | 4,611 out of 5,772 | 20th |
Major group Chemicals And Allied Products | 1,686 out of 2,075 | 19th |
Industry group Drugs | 1,396 out of 1,731 | 19th |
Industry Pharmaceutical Preparations | 1,091 out of 1,333 | 18th |
Source: SEC filing on April 30, 2018.
Lowinger's colleagues
We found two more compensation records of executives who worked with Timothy B. Lowinger at Mersana Therapeutics in 2017.
News
Mersana Therapeutics CEO Anna Protopapas' 2023 pay jumps 56% to $4.5M
April 26, 2024
Mersana Therapeutics CEO Anna Protopapas' 2022 pay falls 66% to $2.8M
April 28, 2023
Mersana Therapeutics CEO Anna Protopapas' 2021 pay jumps 226% to $8.3M
April 29, 2022
Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
April 27, 2021
Mersana Therapeutics CEO Anna Protopapas' 2019 pay falls 33% to $1.7M
April 20, 2020
Mersana Therapeutics CEO Anna Protopapas' 2018 pay jumps 184% to $2.6M
April 23, 2019